Objective To evaluate the relationship between telomerase activation and chemosensitivity in epithelial ovarian cancer cell lines.
目的探讨端粒酶活性与上皮性卵巢癌细胞系化学敏感性的关系。
AIM: to identify the key factors responsible for drug resistance in different ovarian cancer cell lines using protein microarray system.
目的：抗体蛋白质芯片初步筛选常见细胞因子在卵巢癌耐药细胞株中的表达。
Objective: To study the inhibition of OPCML to ovarian cancer cell lines using a lentiviral vector system for efficient gene transduction.
目的：探讨重组慢病毒介导的体外转导OPCML基因的可行性及其对卯巢上皮性癌（卵巢癌）细胞的抑制作用。
Chemotherapy given in combination with ligands for the peroxisome proliferator-activated receptor - (PPAR) synergistically inhibits the growth of lung and ovarian cancer cell lines.
化疗药物联合过氧化物酶体增殖物激活受体(PPAR)的配体能够协同抑制肺细胞癌及卵巢癌细胞。
Chemotherapy given in combination with ligands for the peroxisome proliferator-activated receptor - (PPAR) synergistically inhibits the growth of lung and ovarian cancer cell lines.
化疗药物联合过氧化物酶体增殖物激活受体(PPAR)的配体能够协同抑制肺细胞癌及卵巢癌细胞。
应用推荐